Clarivate Plc's (NYSE:CLVT) Popularity With Investors Is Under Threat From Overpricing

With a median price-to-sales (or "P/S") ratio of close to 1.3x in the Professional Services industry in the United States, you could be forgiven for feeling indifferent about Clarivate Plc's (NYSE:CL

Simply Wall StJul 4 03:01

Express News | Clarivate PLC : Oppenheimer Cuts Target Price to $9 From $10

BreakingsJul 3 20:19

Oppenheimer Trims Price Target on Clarivate to $9 From $10, Maintains Outperform Rating

Clarivate (CLVT) has an average rating of outperform and price targets ranging from $6 to $10, according to analysts polled by Capital IQ. Price: 5.60, Change: +0.04, Percent Change: +0.72

MT NewswiresJul 3 20:16

JAAD RANKS NO. 1 AMONG DERMATOLOGY JOURNALS

The Journal of the American Academy of Dermatology's impact factor remains #1 in field ROSEMONT, Ill. , July 2, 2024 /PRNewswire/ -- The Journal of the American Academy of Dermatology remains the top

PR NewswireJul 2 22:38

Clarivate Identifies Six Breakthrough MedTech Trends in 2024 Set to Unlock New Industry Opportunities

Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the release of the MedTech Trends to Watch 2024 report, the second installment in a two-part series offering a predictive analysis of emerging trends shaping the MedTech industry. Highlighting both challenges—such as economic uncertainty, regulatory shifts and fragile supply chains—and opportunities such as the rise of ambulatory surgical centers and AI in MedTech, the report provides a comprehensive outlook on industry trajectory.

PR NewswireJul 2 15:00

Clarivate Launches IP Collaboration Hub

Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today launched the IP Collaboration Hub at the 2024 Clarivate...

PR NewswireJun 24 15:00